UncategorizedImmunis partners with Springbok Analytics to assess IMMUNA’s impact on sarcopenia – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedSeragon launches Enlivien sleep and longevity optimizer in US – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedNeuronascent advances NNI-362 with human trial publication, canine plans – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedEvernow partners with Ōura to enhance personalized menopause care – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedImmunis named among top 25 biotech companies for 2025 by HTR – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedReviveHealth debuts integrated weight health solution for employers – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedIsaac Health raises $10.5m to expand dementia care technology – Longevity.Technology Empower Meds / August 18, 2025
UncategorizedBioAge Labs doses first participant in phase 1 trial of BGE-102 – Longevity.Technology Empower Meds / August 18, 2025
